Literature DB >> 10467795

Optimal dose of nalbuphine for treatment of intrathecal-morphine induced pruritus after caesarean section.

C Somrat1, K Oranuch, U Ketchada, S Siriprapa, R Thipawan.   

Abstract

OBJECTIVE: To search for the optimal dosage of nalbuphine relief of intrathecal-morphine induced pruritus after caesarean section.
METHODS: Ninety parturients who developed moderate to severe pruritus caused by intrathecal morphine after caesarean section were randomly allocated into 3 groups receiving 2, 3 and 4 mg of intravenous nalbuphine respectively. The improvement of pruritus and adverse effects of nalbuphine such as increasing pain scores, nausea, vomiting, sedation and respiratory depression were evaluated at 15 minutes after nalbuphine administration.
RESULTS: Percentage of successful treatment of pruritus with 2, 3 and 4 mg, nalbuphine were 86.7, 96.7 and 100, respectively (p = 0.12). There was no statistically significant difference in adverse effects. No evidence of respiratory depression was detected. However, there was significant increase in pain scores in group of 4 mg nalbuphine (p = 0.004).
CONCLUSIONS: Nalbuphine of 2 to 3 mg was considered to be adequate in treatment of intrathecal morphine induced pruritus after caesarean section without increasing pain scores or causing other side effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10467795     DOI: 10.1111/j.1447-0756.1999.tb01149.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  8 in total

Review 1.  Intrathecal opioids for combined spinal-epidural analgesia during labour.

Authors:  Peter DeBalli; Terrance W Breen
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  Neuraxial opioid-induced itch and its pharmacological antagonism.

Authors:  Mei-Chuan Ko
Journal:  Handb Exp Pharmacol       Date:  2015

Review 3.  Pathophysiology and management of opioid-induced pruritus.

Authors:  Arjunan Ganesh; Lynne G Maxwell
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  Side Effects and Efficacy of Neuraxial Opioids in Pregnant Patients at Delivery: A Comprehensive Review.

Authors:  Sarah Armstrong; Roshan Fernando
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

5.  A comparision of nalbuphine with morphine for analgesic effects and safety : meta-analysis of randomized controlled trials.

Authors:  Zheng Zeng; Jianhua Lu; Chang Shu; Yuanli Chen; Tong Guo; Qing-ping Wu; Shang-long Yao; Ping Yin
Journal:  Sci Rep       Date:  2015-06-03       Impact factor: 4.379

Review 6.  Emerging Therapeutic Options for Chronic Pruritus.

Authors:  Radomir Reszke; Piotr Krajewski; Jacek C Szepietowski
Journal:  Am J Clin Dermatol       Date:  2020-10       Impact factor: 7.403

7.  Activity of opioid ligands in cells expressing cloned mu opioid receptors.

Authors:  Parham Gharagozlou; Hasan Demirci; J David Clark; Jelveh Lameh
Journal:  BMC Pharmacol       Date:  2003-01-04

8.  Comparative study between nalbuphine and ondansetron in prevention of intrathecal morphine-induced pruritus in women undergoing cesarean section.

Authors:  Ahmed A M Moustafa; Amr Samir Baaror; Ibrahim A Abdelazim
Journal:  Anesth Essays Res       Date:  2016 May-Aug
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.